Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
591 trials across Europe, recruiting first
Study on Daridorexant for Treating Insomnia in Patients with Insomnia and Nocturia
GermanyStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
AustriaStudy on Overactive Bladder Treatment for Women Using Clostridium Botulinum Neurotoxin Type A and Vibe System
Portugal
BelgiumStudy on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery
FranceStudy on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1
BelgiumLong-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients
AustriaStudy of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer
CzechiaStudy of Peginterferon Alfa-2a for Patients with Extramembranous Glomerulonephritis
FranceStudy on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer
BelgiumStudy on Preventing BK Virus Infection in Kidney Transplant Patients Using Mycophenolic Acid, Mycophenolate Mofetil, and Sirolimus
SpainStudy of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer
FranceThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
